Total Payments
$6,918
2024 Payments
$4,227
Companies
20
Transactions
251
Medicare Patients
2,308
Medicare Billing
$161,093
Payment Breakdown by Category
Food & Beverage$5,962 (86.2%)
Consulting$615.00 (8.9%)
Education$341.33 (4.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,962 | 246 | 86.2% |
| Consulting Fee | $615.00 | 1 | 8.9% |
| Education | $341.33 | 4 | 4.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| LEO Pharma Inc. | $1,176 | 34 | $0 (2024) |
| GENZYME CORPORATION | $901.39 | 22 | $0 (2024) |
| ABBVIE INC. | $783.10 | 46 | $0 (2024) |
| Incyte Corporation | $745.05 | 20 | $0 (2024) |
| PFIZER INC. | $707.65 | 30 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $454.95 | 16 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $391.75 | 12 | $0 (2024) |
| UCB, Inc. | $357.76 | 14 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $343.78 | 18 | $0 (2024) |
| Amgen Inc. | $209.58 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,227 | 156 | LEO Pharma Inc. ($1,154) |
| 2023 | $1,503 | 52 | Incyte Corporation ($264.74) |
| 2022 | $387.42 | 17 | GENZYME CORPORATION ($122.51) |
| 2021 | $799.65 | 26 | PFIZER INC. ($147.09) |
All Payment Transactions
251 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $26.67 | General |
| Category: DERMATOLOGY | ||||||
| 12/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.69 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: Dermatology | ||||||
| 12/06/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $146.21 | General |
| Category: Immunology | ||||||
| 12/06/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $23.18 | General |
| 12/06/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: Inflammation | ||||||
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.43 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $28.49 | General |
| Category: Dermatology | ||||||
| 12/02/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $41.21 | General |
| Category: Immunology | ||||||
| 11/26/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: DERMATOLOGY | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $5.95 | General |
| Category: Immunology | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.91 | General |
| Category: Immunology | ||||||
| 11/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $6.06 | General |
| Category: Dermatology | ||||||
| 11/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $1.67 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.84 | General |
| Category: Immunology | ||||||
| 10/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: Immunology | ||||||
| 10/17/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $6.10 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 827 | 1,363 | $320,696 | $51,080 |
| 2022 | 15 | 1,481 | 2,585 | $599,843 | $110,013 |
Total Patients
2,308
Total Services
3,948
Medicare Billing
$161,093
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 110 | 130 | $45,539 | $9,345 | 20.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 134 | 153 | $38,013 | $6,953 | 18.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 54 | 58 | $39,106 | $6,825 | 17.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 106 | 110 | $45,553 | $6,230 | 13.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 58 | 61 | $27,928 | $4,391 | 15.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 132 | 149 | $39,624 | $4,365 | 11.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 49 | 93 | $19,091 | $3,499 | 18.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 104 | 529 | $14,553 | $2,418 | 16.6% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 13 | 13 | $15,776 | $2,287 | 14.5% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 26 | 26 | $13,371 | $1,722 | 12.9% |
| 11601 | Removal of cancer skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 13 | 13 | $11,825 | $1,156 | 9.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $5,435 | $972.96 | 17.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 16 | 16 | $4,883 | $916.57 | 18.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 257 | 330 | $81,989 | $19,024 | 23.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 197 | 246 | $101,874 | $16,680 | 16.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 116 | 144 | $50,443 | $12,340 | 24.5% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 80 | 97 | $65,401 | $11,471 | 17.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 240 | 323 | $85,895 | $10,654 | 12.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 102 | 123 | $56,314 | $9,995 | 17.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 90 | 160 | $32,845 | $6,208 | 18.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 200 | 956 | $26,300 | $4,870 | 18.5% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 17 | 18 | $21,843 | $4,164 | 19.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 54 | 54 | $16,481 | $3,607 | 21.9% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 35 | 36 | $18,513 | $3,435 | 18.6% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 17 | 20 | $14,185 | $2,438 | 17.2% |
About Allison Smith
Allison Smith is a Medical healthcare provider based in Pomona, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/09/2017. The National Provider Identifier (NPI) number assigned to this provider is 1619403847.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Allison Smith has received a total of $6,918 in payments from pharmaceutical and medical device companies, with $4,227 received in 2024. These payments were reported across 251 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($5,962).
As a Medicare-enrolled provider, Smith has provided services to 2,308 Medicare beneficiaries, totaling 3,948 services with total Medicare billing of $161,093. Data is available for 2 years (2022–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical
- Other Specialties Physician Assistant
- Location Pomona, CA
- Active Since 05/09/2017
- Last Updated 01/03/2022
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1619403847
Products in Payments
- DUPIXENT (Biological) $1,157
- ADBRY (Biological) $1,057
- OPZELURA (Drug) $565.07
- EUCRISA (Drug) $508.61
- RINVOQ (Biological) $395.78
- Sotyktu (Drug) $391.75
- SKYRIZI (Biological) $366.62
- Bimzelx (Biological) $244.76
- Otezla (Drug) $209.58
- VTAMA (Drug) $196.86
- Winlevi (Drug) $164.72
- Zoryve (Drug) $128.28
- OLUMIANT (Drug) $120.25
- CIBINQO (Drug) $119.53
- Cimzia (Drug) $113.00
- CardioMEMS HF System (Device) $92.78
- ILUMYA (Biological) $84.07
- LIBTAYO (Biological) $79.63
- LITFULO (Drug) $79.51
- CARDIOMEMS (Device) $64.72
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Doctors in Pomona
Allegra Danna-Demott, Pa-C, PA-C
Medical — Payments: $12,163
Medical $12,163
Debra Priore
Medical — Payments: $12,055
Medical $12,055
Mr. Brian Hughes, P.a, P.A
Medical — Payments: $3,333
Medical $3,333
Joana Lu, Pa-C, PA-C
Medical — Payments: $2,003
Medical $2,003
Roxana Manuel, Pa-C, PA-C
Medical — Payments: $1,934
Medical $1,934
John Hoang, Pa-C, PA-C
Medical — Payments: $1,344
Medical $1,344